Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals
Liability effects on the economic performance of the pharmaceutical industry play a prominent role in the debate about the economic effects of product liability in the United States. The author analyzes incentive effects on company decisions, implications for economic outcomes such as drug safety an...
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
RAND Corporation
2013
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_115106 | ||
| 005 | 20231005 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231005s2013 xx |||||o ||| 0|eng d | ||
| 020 | |a j.ctt2jc9fj | ||
| 020 | |a 9780833079916 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.7249/j.ctt2jc9fj |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a VSD |2 bicssc | |
| 072 | 7 | |a LNB |2 bicssc | |
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Garber, Steven |4 auth | |
| 245 | 1 | 0 | |a Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals |
| 260 | |b RAND Corporation |c 2013 | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Liability effects on the economic performance of the pharmaceutical industry play a prominent role in the debate about the economic effects of product liability in the United States. The author analyzes incentive effects on company decisions, implications for economic outcomes such as drug safety and effectiveness, and suggests how public policy changes could mitigate liability-based sources of inefficient decisions of pharmaceutical companies. | ||
| 540 | |a All rights reserved |4 http://oapen.org/content/about-rights | ||
| 546 | |a English | ||
| 650 | 7 | |a Law, citizenship & rights for the lay person |2 bicssc | |
| 650 | 7 | |a Private / Civil law: general works |2 bicssc | |
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a Health Sciences | ||
| 653 | |a Law | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://www.jstor.org/stable/10.7249/j.ctt2jc9fj |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/115106 |7 0 |z DOAB: description of the publication |